Stonvex
Stonvex
StonvexWhat you need to know right now
This is an algorithmic assessment of current technical conditions, not investment advice. Past performance does not guarantee future results.
Real-time TradingView chart with full indicator set.
Last 7 days, powered by Finnhub. Tap Analyze to classify direction.
Loading latest news…
Pick the depth your tier unlocks. Logged-in Pro/Premium users automatically get the deeper report.
Free preview · 3 reports / hour · No sign-up required
Factor grades, AI Copilot, personalized ranking, and deeper event analysis.
Upgrade to Pro →Next report date, year-over-year trend, and recent quarter history.
5-factor analysis: Valuation, Growth, Profitability, Momentum, Financial Health.
Factor scoring needs Finnhub-supplied fundamentals — Finnhub returned no fundamental metrics for this ticker. Common for ETFs, foreign filers without US listing depth, recent IPOs, and thinly-traded OTC names.
6-factor scoring with sector-relative rank. Updated daily.
Share this analysis with other traders
Disclaimer: The content on this page is for informational and educational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consult a licensed financial advisor before making any investment decisions.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Date | Open | Close | Δ | Vol |
|---|---|---|---|---|
| 05-11 | $36.99 | $34.36 | -7.11% | 0.7M |
| 05-12 | $34.78 | $32.48 | -6.61% | 0.6M |
| 05-13 | $32.00 | $31.34 | -2.06% | 0.6M |
| 05-14 | $31.55 | $31.21 | -1.08% | 0.6M |
| 05-15 | $31.70 | $30.85 | -2.68% | 0.7M |
Documents are served directly from sec.gov / the issuer's website — Stonvex does not proxy or store filings.
These are published opinions from external sell-side analysts — not Stonvex recommendations. Ratings may change without notice, may conflict with each other, and may be wrong. Not investment advice.
Consensus aggregated from publicly disclosed sell-side analyst ratings. Stonvex is not a registered investment advisor and does not endorse any of the ratings shown. Past analyst ratings do not predict future price movements.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $281.14M | $1.13B | $833.11M | $552.00M |
Operating Income | $51.45M | $190.75M | $131.61M | $77.00M |
Net Income | $31.14M | $114.97M | $78.28M | $30.80M |
EPS (Diluted) | $0.67 | $2.37 | $1.61 | $0.63 |
Total Assets | $2.11B | $2.39B | $2.10B | $2.63B |
Total Liabilities | $2.07B | $2.31B | $2.00B | $2.56B |
Cash & Equivalents | $34.10M | $38.91M | $38.26M | $41.57M |
Free Cash Flow OCF − CapEx | $49.79M | $257.78M | $202.74M | $66.99M |
Shares Outstanding | 46.30M | 46.71M | 48.06M | 48.51M |
Founded in 1981, Blackbaud provides software solutions designed to serve the "social good" community, including nonprofits, foundations, corporations, educational institutions, healthcare institutions, and individual change agents. Through M&A and organic product development efforts, the company has also moved into related areas outside core fundraising, notably into K-12 schools. The firm enables more than $100 billion in donations annually across a customer base in excess of 40,000 customers in over 100 countries.